Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
Ciena is at the center of the AI infrastructure buildout: optical networking gear and automation software are seeing multi-year demand growth. The stock has pulled in from recent highs on convertible-offering fears and sector volatility. For patient traders who want exposure to the optics tailwind without paying full froth, a structured long with a…
Mueller Industries (MLI) is a cash-rich metal fabricator with accelerating revenue and record quarterly earnings. The stock has pulled back into oversold technicals; this trade proposes buying on an intermediate weakness to $55 with a $68 target over the next 45 trading days and a $50.50 stop.
Ares Management (ARES) has been punished with the broader private-credit selloff and heavy shorting, yet the firm still generates strong free cash flow, posts solid returns on equity, and has strategic optionality after recent acquisitions. Technicals show elevated short activity and neutral RSI, creating a favorable risk/reward for a mid-term (45 …
Celsius (CELH) trades at a premium multiple despite legal overhangs, rising short interest and a recent 50% drawdown from highs. We see a mid-term short trade into a re-rating as investigations and execution risk collide with stretched expectations.
Nvidia remains the dominant AI chip leader, but a reported delay in a new networking/platform rollout creates a tactical window for competitors like Credo to capture time-sensitive data-center orders. With sentiment stretched, technical momentum cooling and a rich valuation, a structured short against NVDA over the next 45 trading days makes sense …
MercadoLibre's market share, high free cash flow and 49% revenue growth backdrop argue for buying the dip. Near-term e-commerce margin pressure and higher fintech provisions have dented profitability, creating a window to enter a long trade with defined risk. This trade targets a rebound toward the low- to mid-$2,000s over a mid-term 45 trading day…
Discovery Silver (DSVSF) trades like a pure silver developer but carries a second-order opportunity: infrastructure-led re-rating as the company advances the Cordero feasibility package and moves toward permitting and project financing. With a $5.37B market cap, bullish technicals and improving liquidity, the mid-term trade is to buy a measured pos…
Polaris is a cyclical recreational-products name that looks inexpensive on sales, yields 4.3% and carries a nascent growth optionality from autonomous ground vehicles and electric power-sports trends. The trade: a tactical long with entry at $64.34, stop at $58.00 and target at $75.00 over a mid-term 45-trading-day horizon, sized for investors who …
Rubrik's recent beat and raised fiscal 2027 guidance show the company has turned the corner on profitability while staking out a lead in agentic data protection. The fundamentals justify a constructive trade, but technical overextension and rich valuation create tangible momentum risk. Entry on a measured pullback, defined stop and a 180-trading-da…
IonQ combines industry-leading trapped-ion gate fidelity with accelerating commercial traction and explicit government procurement tailwinds. Valuation is rich, but recent multiple de-rate and improving revenue trends create an asymmetric mid-to-long-term trade. Plan: enter at $49.00, trail risk to $40.00, target $70.00 over a 180 trading-day horiz…
TransDigm (TDG) is a cash-generative aerospace components specialist trading at a premium but supported by a 47% operating margin, recurring aftermarket sales, $1.85B free cash flow and targeted acquisitions. We upgrade to Strong Buy with an entry of $1346.92, a $1600 target (180 trading days) and a $1200 stop loss. Catalysts include M&A integratio…
United Therapeutics (UTHR) is trading with favorable fundamentals and a clear catalyst cadence: a string of 2026 Tyvaso filings, stronger PAH pipeline readouts, and meaningful shareholder repurchases. At roughly $547 today, the stock offers a mix of near-term regulatory re-ratings and durable cash flow that justify a buy with a disciplined stop. Th…
After months of retail-driven volatility and headline chasing, Reddit looks positioned for a fundamentals-led move. Strong free cash flow, healthy returns on equity, bullish technicals and fading meme-stock attention create a favorable risk/reward for a mid-term long trade. Entry at $200.86, stop $180.00, target $250.00 over ~45 trading days.
Visa is using partnerships and new on‑chain rails to convert crypto disruption into incremental franchise growth. The company’s network economics, $21.2B in free cash flow and 51% ROE give it optionality to monetize Open USD and other tokenized-payment flows. We lay out a concrete long trade with entry, stop and target, plus catalysts and risks.
I added MercadoLibre (MELI) as my third-largest position after a sizable pullback. The business combines high-growth e-commerce with an expanding fintech moat, generates meaningful free cash flow, and trades at a premium but not an extreme multiple for its growth. This is an actionable long with entry at $1807.13, a stop at $1520.00 and a primary t…
Zoom trades around $85 and looks cheap given $7+ EPS power, a market cap near $24.9B, and an indirect position in Anthropic. The risk-reward favors a disciplined long: entry $85.02, stop $75.00, target $110.00 over a 180-trading-day horizon, with clear catalysts and a finite list of risks to monitor.
Columbus McKinnon (CMCO) is a cyclical, highly leveraged industrial whose shares trade well below prior highs after a sharp reset. The business still generates industrial exposure, a modest dividend and a reasonable market-cap base ($404M) while enterprise value sits north of $2.6B because of leverage. This trade idea looks for a mid-term rebound t…
Meta’s announcement that it will commercialize excess AI infrastructure as Meta Compute sent shares through a volatile week. The market punished the stock on capex concerns; I see the move as an overreaction. Meta still prints strong ad growth, generates $48.3B in free cash flow, and trades at ~21x earnings with a $1.52T market cap. This is a mediu…
Jensen Huang's recent push against bespoke ASICs has exposed Nvidia to renewed competitive, pricing and regulatory risk. We are downgrading the stock and proposing a mid-term short: entry at $680.00, target $520.00, stop loss $760.00. The trade targets a re-rating driven by demand shifts, ASP pressure and coalition-driven customer negotiation.
Allegro is a niche leader in sensor and high-voltage power ICs that stands to benefit from a shift to 800-VDC architectures across EVs, robotics and industrial systems. Strong top-line execution, healthy free cash flow and improving leadership bench make a buyable setup after recent consolidation. The trade below balances upside toward the 52-week …
Palantir has the revenue growth, margins and cash-flow profile that can support a dramatically higher equity value if AIP achieves commercial scale. At $132.62 today we lay out a concrete trade: entry $132.62, target $602.00 (ambitious multi-year target consistent with ~40% annualized returns through 12/31/2030), stop $102.00. The trade is high-ris…
Avio is a leveraged, high-beta play on Europe’s sovereign space agenda. With Vega family upgrades, a growing pipeline of European institutional demand, and near-term contract catalysts, this is a speculative buy for risk-tolerant investors looking for asymmetric upside. Use tight sizing and a well-defined stop - this is a high-risk, event-driven tr…
EOS is a closed-end equity income fund trading near the low end of its 52-week range with an 8.29% yield, a sub-1.0 PB and a single-digit P/E. For yield seekers comfortable with CEF dynamics, a mid-term long (45 trading days) offers upside to the 52-week high while collecting monthly distributions. Manage position size around the stop and keep an e…
Tenax Therapeutics (TENX) has run up into a near-term data event for TNX-103. The balance sheet looks clean, market cap is light-moderate for a Phase 3 biotech, and technical momentum is strong. That combination argues for a Hold for existing holders and a cautious, size-limited long only on a defined pullback or with tight stops ahead of the Augus…
Meta's plan to sell excess AI compute as 'Meta Compute' reframes expensive data-center capex from a pure cost sink into a revenue generator. Combined with a still-robust Family of Apps business (33% y/y revenue growth cited in recent coverage) and attractive cash flow ($48.25B FCF), the stock looks primed for a re-rating. This is a swing trade idea…
